May 15, 2019
Powles T et al. Nature Medicine 2019;25:1706–1714.
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
You might also be interested by
Brochures & Infographics
Immunohistochemistry (IHC) Biomarker List
February 29, 2024
Histopathology
More infoPosters
Seeing the Whole Picture: A Comparative Analysis of Digital Pathology Whole Slide Scanners
October 24, 2023
Histopathology
More info